The woman who turned BTG into a diverse pharmaceuticals and life sciences company could bank up to £20million from its takeover.

Dame Louise Makin, who took charge in 2004, could net the package in bonuses, shares and performance pay after BTG’s £3.3billion sale to Boston Scientific.

The US firm offered 840p a share, almost 37 per cent more than BTG’s closing price last Monday – the day before the approach – of 615p.

BTG shares have soared 34 per cent since then to 826p on Friday.

-----------------------------------------------------------------------

Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.